AtriCure reports Q1 EPS ,0c consensus (6c)

Reports Q1 revenue $141.2M, consensus $139.8M. “Our first quarter results reflect the durability of AtriCure’s (ATRC) growth model, fueled by disciplined execution and increased adoption of our innovative products,” said Michael Carrel, President and Chief Executive Officer at AtriCure. “Strong revenue growth, combined with improving profitability and meaningful advancement across our clinical initiatives, gives us confidence that we are building a foundation to drive the next era of growth and value creation for AtriCure and our shareholders.”